Washington, DC - The U.S. Food and Drug Administration approved Adlyxin (lixisenatide), a once-daily injection to improve glycemic control (blood sugar levels), along with diet and exercise, in adults with type 2 diabetes.

West Lafayette, Indiana - Employees under prolonged workplace pressures face serious consequences to their health, according to a working paper issued by the National Bureau for Economic Research.

Stanford, California - Around the world people have been living longer, with life expectancy pushing past 70 in many countries. However, people aren’t simply living longer on average: Inequality among individuals in the length of life has shrunk over time.

Cambridge, Massachusetts - Ever waited entirely too long at your doctor’s office for an appointment to start? The long wait may soon be over: An MIT spinout’s schedule-optimizing software that gets more patients seen more quickly could soon be used by tens of thousands of health care providers across the country, after a recent acquisition by a major health care services company.

Washington, DC - The U.S. Food and Drug Administration today approved safety labeling changes for a class of antibiotics, called fluoroquinolones, to enhance warnings about their association with disabling and potentially permanent side effects and to limit their use in patients with less serious bacterial infections.

Durham, North Carolina - Walking briskly on a regular basis may be more effective than vigorous jogging for improving glucose control in individuals with pre-diabetes, according to research from Duke Health.